FY21 Results Release
Filed with ASX · · 2 pages · English
Revenues of $76.57M, 6.6% increase on prior corresponding period (PCP); 16.0% organic growth on a constant currency basis Proforma EBITDA significantly exceeded forecast at $9.95M, up 89.0% on PCP Growth across most product categories and key customers Revenue and proforma EBITDA 2.6% and 5.2% respectively ahead of Prospectus forecast The FY21 EBITDA of $5.47M is inclusive of IPO related
Trajan Group Holdings Ltd on 6ix
In the deck
Earlier from Trajan
Later from Trajan
- FY21 Results Presentation
- Investment in direct-to-consumer health measurement business
- Trajan Group acquires Axel Semrau GmbH
- Trajan Group acquires LEAP PAL Parts
- Trajan acquires Neoteryx LLC
Follow Trajan into a list and get an email when it puts out news.
Follow Trajan